Thyroid disorders during pregnancy

Endocrinology and Metabolism Clinics of North America

Volumn 43, Issue 2, 2014, Pages 573-597

  Nathan, Nisha ^a   Sullivan, Shannon D ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Autoimmune thyroid disease; Hyperthyroidism; Hypothyroidism; Isolated hypothyroxinemia; Pregnancy; Thyroid gland physiology

Indexed keywords

ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHORIONIC GONADOTROPIN; LEVOTHYROXINE; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIONAMIDE; THYROGLOBULIN; THYROID PEROXIDASE ANTIBODY; THYROTROPIN;

ADVERSE OUTCOME; AUTOIMMUNE DISEASE; DRUG EFFECT; ECHOGRAPHY; EUTHYROIDISM; FETUS MONITORING; GESTATIONAL TRANSIENT THYROTOXICOSIS; GRAVES DISEASE; HIGH RISK PREGNANCY; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; ISOLATED MATERNAL HYPOTHYROXINEMIA; MASS SCREENING; MATERNAL CARE; NEWBORN CARE; OUTCOME ASSESSMENT; PATIENT COUNSELING; PHYSIOLOGICAL PROCESS; POSTPARTUM THYROIDITIS; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROGENY; PUERPERIUM; REVIEW; SUBCLINICAL HYPOTHYROIDISM; THYROID CANCER; THYROID DISEASE; THYROID NODULE; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL; TREATMENT PLANNING; WOMEN'S HEALTH; FEMALE; PATHOPHYSIOLOGY; PREGNANCY COMPLICATIONS; THYROID DISEASES; THYROID GLAND;

FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; THYROID DISEASES; THYROID GLAND;

EID: 84901494287     PISSN: 08898529     EISSN: 15584410     Source Type: Journal    
DOI: 10.1016/j.ecl.2014.02.008     Document Type: Review

References (134)

1. Stagnaro-Green A. Overt hyperthyroidism and hypothyroidism during pregnancy. Clin Obstet Gynecol 2011, 54(3):478-487.
2. Hollowell J.G., Staehling N.W., Flanders W.D., et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002, 87(2):489-499.
3. Abalovich M., Amino N., Barbour L.A., et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2007, 92(Suppl 8):S1-S47.
4. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 1997, 18(3):404-433.
5. Alexander E.K., Marqusee E., Lawrence J., et al. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 2004, 351(3):241-249.
6. Kaplan M.M. Monitoring thyroxine treatment during pregnancy. Thyroid 1992, 2(2):147-152.
7. Mandel S.J., Larsen P.R., Seely E.W., et al. Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med 1990, 323(2):91-96.
8. Glinoer D., McGuire R.A., Gershengorn M.C., et al. Effects of estrogen on thyroxine-binding globulin metabolism in rhesus monkeys. Endocrinology 1977, 100(1):9-17.
9. Glinoer D., Gershengorn M.C., Dubois A., et al. Stimulation of thyroxine-binding globulin synthesis by isolated rhesus monkey hepatocytes after in vivo beta-estradiol administration. Endocrinology 1977, 100(3):807-813.
10. Ain K.B., Mori Y., Refetoff S. Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration. J Clin Endocrinol Metab 1987, 65(4):689-696.
11. Skjoldebrand L., Brundin J., Carlstrom A., et al. Thyroid associated components in serum during normal pregnancy. Acta Endocrinol 1982, 100(4):504-511.
12. Glinoer D., de Nayer P., Bourdoux P., et al. Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab 1990, 71(2):276-287.
13. Smits G., Govaerts C., Nubourgh I., et al. Lysine 183 and glutamic acid 157 of the TSH receptor: two interacting residues with a key role in determining specificity toward TSH and human CG. Mol Endocrinol 2002, 16(4):722-735.
14. Dworkin H.J., Jacquez J.A., Beierwaltes W.H. Relationship of iodine ingestion to iodine excretion in pregnancy. J Clin Endocrinol Metab 1966, 26(12):1329-1342.
15. Burrow G.N., Fisher D.A., Larsen P.R. Maternal and fetal thyroid function. N Engl J Med 1994, 331(16):1072-1078.
16. Stagnaro-Green A., Abalovich M., Alexander E., et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011, 21(10):1081-1125.
17. Shields B., Hill A., Bilous M., et al. Cigarette smoking during pregnancy is associated with alterations in maternal and fetal thyroid function. J Clin Endocrinol Metab 2009, 94(2):570-574.
18. La'ulu S.L., Roberts W.L. Ethnic differences in first-trimester thyroid reference intervals. Clin Chem 2011, 57(6):913-915.
19. Koreevaar T.I., Medici M., de Rijke Y.B., et al. Ethnic differences in maternal thyroid parameters during pregnancy. J Clin Endocrinol Metab 2013, 98(9):3678-3686.
20. Mandel S.J., Spencer C.A., Hollowell J.G. Are detection and treatment of thyroid insufficiency in pregnancy feasible?. Thyroid 2005, 15(1):44-53.
21. Kahric-Janicic N., Soldin S.J., Soldin O.P., et al. Tandem mass spectrometry improves the accuracy of free thyroxine measurements during pregnancy. Thyroid 2007, 17(4):303-311.
22. Lee R.H., Spencer C.A., Mestman J.H., et al. Free T4 immunoassays are flawed during pregnancy. Am J Obstet Gynecol 2009, 200(3):260.e261-260.e266.
23. Stagnaro-Green A., Pearce E. Endocrine disorders in pregnancy. Nature 2012, (8):650-657.
24. Vaidya B., Anthony S., Bilous M., et al. Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high-risk case finding?. J Clin Endocrinol Metab 2007, 92(1):203-207.
25. Li Y., Shan Z., Teng W., et al. Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25-30 months. Clin Endocrinol 2010, 72(6):825-829.
26. Negro R., Schwartz A., Gismondi R., et al. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab 2010, 95(4):1699-1707.
27. Chang D.L., Leung A.M., Braverman L.E., et al. Thyroid testing during pregnancy at an academic Boston Area Medical Center. J Clin Endocrinol Metab 2011, 96(9):E1452-E1456.
28. Moreno-Reyes R., Glioner D., Van Oyen H., et al. High prevalence of thyroid disorders in pregnant women in a mildly iodine-deficient country: a population based study. J Clin Endocrinol Metab 2013, 98(9):3694-3701.
29. Casey BM. A randomized trial of thyroxine therapy for subclinical hypothyroidism or hypothyroxinemia diagnosed during pregnancy. Thyroid dysfunction and pregnancy: miscarriage, preterm delivery and decreased IQ. Booklet of the Research Summit and Spring Symposium of the ATA. Washington, April 16-17, 2009.
30. Lazarus J. Screening for thyroid dysfunction in pregnancy: is it worthwhile?. J Thyroid Res 2011, 2011:397012. 10.4061/2011/397012.
31. De Groot L., Abalovich M., Alexander E., et al. Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society practice guideline. J Clin Endocrinol Metab 2012, 97(8):2543-2565.
32. Neale D., Burrow G. Thyroid disease in pregnancy. Obstet Gynecol Clin North Am 2004, 31(4):893-905. xi.
33. Abalovich M., Gutierrez S., Alcaraz G., et al. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 2002, 12(1):63-68.
34. Allan W.C., Haddow J.E., Palomaki G.E., et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen 2000, 7(3):127-130.
35. Stagnaro-Green A. Maternal thyroid disease and preterm delivery. J Clin Endocrinol Metab 2009, 94(1):21-25.
36. Leung A.S., Millar L.K., Koonings P.P., et al. Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol 1993, 81(3):349-353.
37. Davis L.E., Leveno K.J., Cunningham F.G. Hypothyroidism complicating pregnancy. Obstet Gynecol 1988, 72(1):108-112.
38. Casey B.M., Dashe J.S., Wells C.E., et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 2005, 105(2):239-245.
39. Ashoor G., Rotas M., Maiz N., et al. Maternal thyroid function at 11-13 weeks of gestation in women with hypothyroidism treated by thyroxine. Fetal Diagn Ther 2010, 28(1):22-27.
40. Cohen N., Levy A., Wiznitzer A., et al. Perinatal outcomes in post-thyroidectomy pregnancies. Gynecol Endocrinol 2011, 27(5):314-318.
41. De Vivo A., Mancuso A., Giacobbe A., et al. Thyroid function in women found to have early pregnancy loss. Thyroid 2010, 20(6):633-637.
42. Su P.Y., Huang K., Hao J.H., et al. Maternal thyroid function in the first twenty weeks of pregnancy and subsequent fetal and infant development: a prospective population-based cohort study in china. J Clin Endocrinol Metab 2011, 96(10):3234-3241.
43. Kuppens S.M., Kooistra L., Wijnen H.A., et al. Maternal thyroid function during gestation is related to breech presentation at term. Clin Endocrinol 2010, 72(6):820-824.
44. Kuppens S.M., Kooistra L., Hasaart T.H., et al. Maternal thyroid function and the outcome of external cephalic version: a prospective cohort study. BMC Pregnancy Childbirth 2011, 11:10.
45. Benhadi N., Wiersinga W.M., Reitsma J.B., et al. Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. Eur J Endocrinol 2009, 160(6):985-991.
46. Cleary-Goldman J., Malone F.D., Lambert-Messerlian G., et al. Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol 2008, 112(1):85-92.
47. Mannisto T., Vaarasmaki M., Pouta A., et al. Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies: a prospective population-based cohort study. J Clin Endocrinol Metab 2009, 94(3):772-779.
48. Haddow J.E., Palomaki G.E., Allan W.C., et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999, 341(8):549-555.
49. Henrichs J., Bongers-Schokking J., Schenk J., et al. Maternal function during early pregnancy and cognitive functioning in early childhood: the generation r study. J Clin Endocrinol Metab 2010, 95(9):4227-4234.
50. Behrooz H.G., Tohidi M., Mehrabi Y., et al. Subclinical hypothyroidism in pregnancy: intellectual development of offspring. Thyroid 2011, 21(10):1143-1147.
51. Lazarus J.H., Bestwick J., Channon S., et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med 2012, 366:493-501.
52. Casey B.M., Dashe J.S., Spong C.Y., et al. Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy. Obstet Gynecol 2007, 109(5):1129-1135.
53. Pop V.J., Brouwers E.P., Vader H.L., et al. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol 2003, 59(3):282-288.
54. Pop V.J., Kuijpens J.L., van Baar A.L., et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol 1999, 50(2):149-155.
55. Negro R., Soldin O.P., Obregon M.J., et al. Hypothyroxinemia and pregnancy. Endocr Pract 2011, 17(3):422-429.
56. Loh J.A., Wartofsky L., Jonklaas J., et al. The magnitude of increased levothyroxine requirements in hypothyroid pregnant women depends upon the etiology of the hypothyroidism. Thyroid 2009, 19(3):269-275.
57. Yassa L., Marqusee E., Fawcett R., et al. Thyroid hormone early adjustment in pregnancy (the THERAPY) trial. J Clin Endocrinol Metab 2010, 95(7):3234-3241.
58. Andersson M., Karumbunathan V., Zimmerman M.B. Global iodine status in 2011 and trends over the past decade. J Nutr 2012, 142:744-750.
59. Leung A.M., Pearce E.N., Braverman L.E. Iodine content of prenatal vitamins in the United States. N Engl J Med 2009, 360:939-940.
60. Negro R., Formoso G., Mangieri T., et al. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 2006, 91(7):2587-2591.
61. Negro R. Thyroid autoimmunity and pre-term delivery: brief review and meta-analysis. J Endocrinol Invest 2011, 34(2):155-158.
62. Chen L., Hu R. Thyroid autoimmunity and miscarriage: a meta-analysis. Clin Endocrinol 2011, 74(4):513-519.
63. Negro R., Schwartz A., Gismondi R., et al. Thyroid antibody positivity in the first trimester of pregnancy is associated with negative pregnancy outcomes. J Clin Endocrinol Metab 2011, 96(6):E920-E924.
64. Abbassi-Ghanavati M., Casey B.M., Spong C.Y., et al. Pregnancy outcomes in women with thyroid peroxidase antibodies. Obstet Gynecol 2010, 116(2 Pt 1):381-386.
65. Pop V.J., de Rooy H.A., Vader H.L., et al. Microsomal antibodies during gestation in relation to postpartum thyroid dysfunction and depression. Acta Endocrinol 1993, 129(1):26-30.
66. Marco M., de Rijke Y., Peeters R., et al. Maternal early pregnancy and newborn thyroid hormone parameters: the generation r study. J Clin Endocrinol Metab 2012, 97(2):646-652.
67. Thangaratinum S., Tan A., Knox E., et al. Association between thyroid auto-antibodies and miscarriage and pre-term birth: meta-analysis of evidence. BMJ 2009, 342:d2616.
68. Ghassabian G., Bongers-Schokking J., de Rijke Y., et al. Maternal thyroid autoimmunity during pregnancy and the risk of attention deficit/hyperactivity problems in children: the generation r study. Thyroid 2012, 22(2):178-186.
69. Glinoer D. Thyroid hyperfunction during pregnancy. Thyroid 1998, 8(9):859-864.
70. Patil-Sisodia K., Mestman J.H. Graves hyperthyroidism and pregnancy: a clinical update. Endocr Pract 2010, 16(1):118-129.
71. Tan J.Y., Loh K.C., Yeo G.S., et al. Transient hyperthyroidism of hyperemesis gravidarum. BJOG 2002, 109(6):683-688.
72. Amino N., Tanizawa O., Mori H., et al. Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease. J Clin Endocrinol Metab 1982, 55(1):108-112.
73. Barbesino G., Tomer Y. Clinical review: clinical utility of TSH receptor antibodies. J Clin Endocrinol Metab 2013, 98(6):2247-2255.
74. Millar L.K., Wing D.A., Leung A.S., et al. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 1994, 84(6):946-949.
75. Davis L.E., Lucas M.J., Hankins G.D., et al. Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 1989, 160(1):63-70.
76. Anselmo J., Cao D., Karrison T., et al. Fetal loss associated with excess thyroid hormone exposure. JAMA 2004, 292(6):691-695.
77. Sheffield J.S., Cunningham F.G. Thyrotoxicosis and heart failure that complicate pregnancy. Am J Obstet Gynecol 2004, 190(1):211-217.
78. Luewan S., Chakkabut P., Tongsong T. Outcomes of pregnancy complicated with hyperthyroidism: a cohort study. Arch Gynecol Obstet 2011, 283(2):243-247.
79. Kempers M.J., van Tijn D.A., van Trotsenburg A.S., et al. Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed. J Clin Endocrinol Metab 2003, 88(12):5851-5857.
80. Medici M., Timmermans S., Visser W. Maternal thyroid hormone parameters during early pregnancy and birth weight: the generation r study. J Clin Endocrinol Metab 2013, 98(1):59-66.
81. Medici M., Ghassabian A., Visser W., et al. Women with early pregnancy urinary iodine levels have an increased risk of hyperthyroid newborns: population based generation r study. Clin Endocrinol 2013, [Epub ahead of print]. 10.1111/cen.12321.
82. Peleg D., Cada S., Peleg A., et al. The relationship between maternal serum thyroid-stimulating immunoglobulin and fetal and neonatal thyrotoxicosis. Obstet Gynecol 2002, 99(6):1040-1043.
83. Zakarija M., McKenzie J.M. Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism. J Clin Endocrinol Metab 1983, 57(5):1036-1040.
84. Polak M., Le Gac I., Vuillard E., et al. Fetal and neonatal thyroid function in relation to maternal Graves' disease. Best Pract Res Clin Endocrinol Metab 2004, 18(2):289-302.
85. Ogilvy-Stuart A.L. Neonatal thyroid disorders. Arch Dis Child Fetal Neonatal Ed 2002, 87:F165-F171.
86. McKenzie J.M., Zakarija M. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid 1992, 2(2):155-159.
87. Momotani N., Ito K., Hamada N., et al. Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol 1984, 20:695-700.
88. Laurberg P., Bournaud C., Karmisholt J., et al. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. Eur J Endocrinol 2009, 160(1):1-8.
89. Ibbertson H.K., Seddon R.J., Croxson M.S. Fetal hypothyroidism complicating medical treatment of thyrotoxicosis in pregnancy. Clin Endocrinol 1975, 4(5):521-523.
90. Ochoa-Maya M.R., Frates M.C., Lee-Parritz A., et al. Resolution of fetal goiter after discontinuation of propylthiouracil in a pregnant woman with Graves' hyperthyroidism. Thyroid 1999, 9(11):1111-1114.
91. Momotani N., Noh J., Oyanagi H., et al. Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status. N Engl J Med 1986, 315(1):24-28.
92. Martinez-Frias M.L., Cereijo A., Rodriguez-Pinilla E., et al. Methimazole in animal feed and congenital aplasia cutis. Lancet 1992, 339(8795):742-743.
93. Clementi M., Di Gianantonio E., Cassina M., et al. Treatment of hyperthyroidism in pregnancy and birth defects. J Clin Endocrinol Metab 2010, 95(11):E337-E341.
94. Di Gianantonio E., Schaefer C., Mastroiacovo P.P., et al. Adverse effects of prenatal methimazole exposure. Teratology 2001, 64(5):262-266.
95. Clementi M., Di Gianantonio E., Pelo E., et al. Methimazole embryopathy: delineation of the phenotype. Am J Med Genet 1999, 83(1):43-46.
96. Yoshihara A., Noh J., Yamaguchi T., et al. Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab 2012 Jul, 97(7):2396-2403.
97. Bahn R.S., Burch H.S., Cooper D.S., et al. The role of propylthiouracil in the management of Graves' disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid 2009, 19(7):673-674.
98. Kim H.J., Kim B.H., Han Y.S., et al. The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study. Am J Gastroenterol 2001, 96(1):165-169.
99. Mandel S.J., Cooper D.S. The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab 2001, 86(6):2354-2359.
100. Azizi F., Bahrainian M., Khamseh M.E., et al. Intellectual development and thyroid function in children who were breast-fed by thyrotoxic mothers taking methimazole. J Pediatr Endocrinol Metab 2003, 16(9):1239-1243.
101. Momotani N., Yamashita R., Makino F., et al. Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil. Clin Endocrinol 2000, 53(2):177-181.
102. Laurberg P., Nygaard B., Glinoer D., et al. Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association. Eur J Endocrinol 1998, 139(6):584-586.
103. Rubin P.C. Current concepts: beta-blockers in pregnancy. N Engl J Med 1981, 305(22):1323-1326.
104. Sherif I.H., Oyan W.T., Bosairi S., et al. Treatment of hyperthyroidism in pregnancy. Acta Obstet Gynecol Scand 1991, 70(6):461-463.
105. Momotani N., Hisaoka T., Noh J., et al. Effects of iodine on thyroid status of fetus versus mother in treatment of Graves' disease complicated by pregnancy. J Clin Endocrinol Metab 1992, 75(3):738-744.
106. Soliman S., McGrath F., Brennan B., et al. Color Doppler imaging of the thyroid gland in a fetus with congenital goiter: a case report. Am J Perinatol 1994, 11(1):21-23.
107. Huel C., Guibourdenche J., Vuillard E., et al. Use of ultrasound to distinguish between fetal hyperthyroidism and hypothyroidism on discovery of a goiter. Ultrasound Obstet Gynecol 2009, 33(4):412-420.
108. Nachum Z., Rakover Y., Weiner E., et al. Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol. Am J Obstet Gynecol 2003, 189(1):159-165.
109. Rotondi M., Cappelli C., Pirali B., et al. The effect of pregnancy on subsequent relapse from Graves' disease after a successful course of antithyroid drug therapy. J Clin Endocrinol Metab 2008, 93(10):3985-3988.
110. Stagnaro-Green A., Roman S.H., Cobin R.H., et al. A prospective study of lymphocyte-initiated immunosuppression in normal pregnancy: evidence of a T-cell etiology for postpartum thyroid dysfunction. J Clin Endocrinol Metab 1992, 74(3):645-653.
111. Lazarus J.H., Hall R., Othman S., et al. The clinical spectrum of postpartum thyroid disease. QJM 1996, 89(6):429-435.
112. Caixas A., Albareda M., Garcia-Patterson A., et al. Postpartum thyroiditis in women with hypothyroidism antedating pregnancy?. J Clin Endocrinol Metab 1999, 84(11):4000-4005.
113. Stagnaro-Green A. Postpartum thyroiditis. Best Pract Res Clin Endocrinol Metab 2004, 18(2):303-316.
114. Lazarus J.H., Ammari F., Oretti R., et al. Clinical aspects of recurrent postpartum thyroiditis. Br J Gen Pract 1997, 47(418):305-308.
115. Alvarez-Marfany M., Roman S.H., Drexler A.J., et al. Long-term prospective study of postpartum thyroid dysfunction in women with insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1994, 79(1):10-16.
116. Stagnaro-Green A., Akhter E., Yim C., et al. Thyroid disease in pregnant women with systemic lupus erythematosus: increased preterm delivery. Lupus 2011, 20(7):690-699.
117. Elefsiniotis I.S., Vezali E., Pantazis K.D., et al. Post-partum thyroiditis in women with chronic viral hepatitis. J Clin Virol 2008, 41(4):318-319.
118. Harris B., Othman S., Davies J.A., et al. Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BMJ 1992, 305(6846):152-156.
119. Stagnaro-Green A., Schwartz A., Gismondi R., et al. High rate of persistent hypothyroidism in a large-scale prospective study of postpartum thyroiditis in southern Italy. J Clin Endocrinol Metab 2011, 96(3):652-657.
120. Kuijpens J.L., Vader H.L., Drexhage H.A., et al. Thyroid peroxidase antibodies during gestation are a marker for subsequent depression postpartum. Eur J Endocrinol 2001, 145(5):579-584.
121. Lucas A., Pizarro E., Granada M.L., et al. Postpartum thyroid dysfunction and postpartum depression: are they two linked disorders?. Clin Endocrinol 2001, 55(6):809-814.
122. Negro R., Greco G., Mangieri T., et al. The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab 2007, 92(4):1263-1268.
123. Kampe O., Jansson R., Karlsson F.A. Effects of L-thyroxine and iodide on the development of autoimmune postpartum thyroiditis. J Clin Endocrinol Metab 1990, 70(4):1014-1018.
124. Rahbari R., Zhang L., Kebebew E. Thyroid cancer gender disparity. Future Oncol 2010, 6(11):1771-1779.
125. Aschebrook-Kilfoy B., Ward M.H., Sabra M.M., et al. Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid 2011, 21(2):125-134.
126. Kung A.W., Chau M.T., Lao T.T., et al. The effect of pregnancy on thyroid nodule formation. J Clin Endocrinol Metab 2002, 87(3):1010-1014.
127. Kuy S., Roman S.A., Desai R., et al. Outcomes following thyroid and parathyroid surgery in pregnant women. Arch Surg 2009, 144(5):399-406.
128. Mazzaferri E.L. Approach to the pregnant patient with thyroid cancer. J Clin Endocrinol Metab 2011, 96(2):265-272.
129. Cooper D.S., Doherty G.M., Haugen B.R., et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2009, 19:1167-1214.
130. 131I: practice recommendations of the American Thyroid Association. Thyroid 2011, 21(4):335-346.
131. Hirsch D., Levy S., Tsvetov G., et al. Impact of pregnancy on outcome and prognosis of survivors of papillary thyroid cancer. Thyroid 2010, 20(10):1179-1185.
132. Leboeuf Rosario P.W., Barroso A.L., Purisch S. The effect of subsequent pregnancy on patients with thyroid carcinoma apparently free of the disease. Thyroid 2007, 17(11):1175-1176.
133. Leboeuf R., Emerick L.E., Martorella A.J., et al. Impact of pregnancy on serum thyroglobulin and detection of recurrent disease shortly after delivery in thyroid cancer survivors. Thyroid 2007, 17(6):543-547.
134. Sioka C., Fotopoulos A. Effects of I-131 therapy on gonads and pregnancy outcome in patients with thyroid cancer. Fertil Steril 2011, 95(5):1552-1559.